See also this year's filing and all EDGAR filings for this company.
PDF Report 0001623526_2020_Stoke_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001623526')"} |
Graph
Absolute values for 0001623526, Stoke Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 226,033,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,512,000 |
| 3 | remainder_Assets | 205,000 |
| 4 | LiabilitiesCurrent | 4,101,000 |
| 5 | LiabilitiesNoncurrent | 221,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,914,000 |
| 9 | ResearchAndDevelopmentExpense | 23,764,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 3,353,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 228,750,000 |
| 1 | Liabilities | 4,322,000 |
| 2 | Expenses | 35,678,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 224,428,000 |
| 5 | NetIncome | -32,325,000 |
| 6 | ComprehensiveNetIncome | -32,325,000 |
| 7 | BaseVar | 136,051,500 |
| 8 | EconomicCapitalRatio | 3.04 |
Edgar->Model Mapping
Feature Distribution
Change over Time
